Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to design and test a decision-making program that is tailored to support adult daughters making healthcare decisions for their parents who are living with memory loss to improve the quality of life of African American families. There are two phases of this research study. The first phase will collect information by surveys and/or interviews. The surveys and interviews will ask questions about demographics (e.g., age, race/ethnicity), culture, health, family dynamics, caregiving, and healthcare experiences. The surveys will be completed by all eligible adult daughters and parents with memory loss in pairs. The interviews will be completed by a smaller number of pairs and by all former adult daughter caregivers. The general scope of topics is caregiving experiences, cultural identity, healthcare decisions for persons living with Alzheimer's disease, and related dementias, health, and well-being. The research team will identify and examine key factors that will lead to designing and testing the feasibility of a culturally tailored prototype intervention for African American dementia dyads/families of persons living with mild to moderate Alzheimer's disease and related dementias.


Clinical Trial Description

This is a survey/questionnaire and interview study that will examine how healthcare decisions are made for African American parents living with memory loss by African American adult daughter caregivers to develop a prototype intervention to improve how these decisions are made and improve the quality of life of African American parents living with memory loss and their African American adult daughter caregivers. Recruitment will occur through established connections at Emory University Goizueta Alzheimer's Disease Research Center Minority Engagement Core, Emory Healthcare Integrated Memory Care Clinic, and Emory University. Recruitment will take place in metro Atlanta and across the United States using a study flyer and video. The flyer will include the phone number, email address of the research team, and a quick response (QR) code for potential participants to contact the research team. The video will give information about the principal investigator (PI) and the research study as a strategy to build rapport with potential participants and assuage distrust in research. Interviews will occur remotely after participants have completed the screening process and are deemed eligible for the study. This is not a no-contact study. The data collected will be de-identified. Privacy of existing data is not a concern. This study has two phases. The first phase will consist of surveys/questionnaires and semi-structured interviews via Zoom from both the parents living with memory loss and their adult daughters as well as semi-structured interviews via Zoom of past adult daughter caregivers whose parent(s) have died or are in long-term care facilities and adult daughters caring for a parent with severe dementia only. For past adult daughter caregivers whose parents have died, the parent will need to have died at least 12 months before enrolling in the study. In the first part of phase two (phase 2a), participants will be key informants who participate in focus group sessions using design thinking strategies to develop the prototype intervention. Key informants will consist of parent-adult daughter dyads, past adult daughter caregivers, and adult daughter caregivers of persons with severe dementia. In the last part of phase two (phase 2b), a pretest/posttest design with two follow-ups will be completed by a new set of African American parent-adult daughter dementia dyad participants. The interactions will include surveys/questionnaires and semi-structured interviews. Data will be collected by computer/tablet and/or telephone. For participants with limited access to a computer/tablet, the surveys may be completed via paper/pencil. The general scope of topics is caregiving experiences, cultural identity, healthcare decisions for persons living with Alzheimer's disease, and related dementias, health, and well-being. In phase one, surveys/questionnaires for persons with mild to moderate dementia will take 0.67 hours and 1 hour for adult daughter caregivers. In phase one, the semi-structured interviews will last 1 hour in total for both parent and daughter. Semi-structured interviews with past adult daughter caregivers and adult daughter caregivers of persons with severe dementia will last approximately 0.75 hours. In phase 2, key informants will have three sessions that last approximately 1.5 hours to assist with the development of the prototype intervention. In phase 2, the pretest/posttest surveys/questionnaire should last 0.33 hours for parents living with dementia and 0.67 hours for adult daughters at baseline and the 2 follow-ups. The last follow-up will consist of one semi-structured interview that will last about 0.5 hours. Phase 1 will allow collecting and analyzing the necessary data to develop the prototype intervention that will be developed in Phase 2a and used in Phase 2b: the intervention phase. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05139290
Study type Interventional
Source Emory University
Contact Kalisha Bonds Johnson, PhD RN PMHNP
Phone 404-727-5937
Email kbonds@emory.edu
Status Recruiting
Phase N/A
Start date July 15, 2022
Completion date December 2026

See also
  Status Clinical Trial Phase
Completed NCT04044495 - Sleep, Rhythms and Risk of Alzheimer's Disease N/A
Completed NCT04079803 - PTI-125 for Mild-to-moderate Alzheimer's Disease Patients Phase 2
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Recruiting NCT04520698 - Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease N/A
Active, not recruiting NCT04606420 - Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease N/A
Recruiting NCT05820919 - Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase N/A
Terminated NCT03672474 - REGEnLIFE RGn530 - Feasibility Pilot N/A
Completed NCT03430648 - Is Tau Protein Linked to Mobility Function?
Recruiting NCT04949750 - Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease N/A
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Recruiting NCT05557409 - A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation Phase 3
Recruiting NCT05288842 - Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
Completed NCT06194552 - A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07 Phase 1
Completed NCT03239561 - Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants Early Phase 1
Completed NCT03184467 - Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients Phase 2
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Terminated NCT03487380 - Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease N/A
Completed NCT05538455 - Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases N/A
Recruiting NCT05328115 - A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease Phase 1
Completed NCT05562583 - SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support N/A